Cargando…

Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway

The present study aimed to determine the role and regulatory mechanism of hydrogen sulfide (H(2)S) in the amelioration of doxorubicin-induced myocardial fibrosis in rats. It is hypothesized that the PI3K/AKT/mTOR signaling pathway is regulated to inhibit endoplasmic reticulum stress (ERS) and autoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Liangui, Liu, Maojun, Chen, Jian, Wu, Qian, Li, Yaling, Yi, Jiali, Zheng, Xia, Zhang, Jingjing, Chu, Chun, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930940/
https://www.ncbi.nlm.nih.gov/pubmed/33649809
http://dx.doi.org/10.3892/mmr.2021.11938
_version_ 1783660187733721088
author Nie, Liangui
Liu, Maojun
Chen, Jian
Wu, Qian
Li, Yaling
Yi, Jiali
Zheng, Xia
Zhang, Jingjing
Chu, Chun
Yang, Jun
author_facet Nie, Liangui
Liu, Maojun
Chen, Jian
Wu, Qian
Li, Yaling
Yi, Jiali
Zheng, Xia
Zhang, Jingjing
Chu, Chun
Yang, Jun
author_sort Nie, Liangui
collection PubMed
description The present study aimed to determine the role and regulatory mechanism of hydrogen sulfide (H(2)S) in the amelioration of doxorubicin-induced myocardial fibrosis in rats. It is hypothesized that the PI3K/AKT/mTOR signaling pathway is regulated to inhibit endoplasmic reticulum stress (ERS) and autophagy to reduce myocardial fibrosis. A total of 40 adult male Sprague Dawley rats were randomly divided into 4 groups (n=10/group). The 4 groups included the normal control group (control group), model group [doxorubicin (Dox) group], H(2)S intervention model group (H(2)S+Dox group) and H(2)S control group (H(2)S group). The model used in the present study was constructed by administering intraperitoneal injections of doxorubicin (3.0 mg/kg every other day; total of 6 injections). In addition, the intervention factor, NaHS and the donor of H(2)S, was also administered by intraperitoneal injection (56 µmol/kg/day), which lasted a month. Pathological changes in the rats were observed using Masson staining and transmission electron microscopy, while the protein expression levels of MMPs/TIMPs, transforming growth factor-β1, cystathionine lyase and PI3K/AKT/mTOR, which are autophagy-related and ERS-related proteins were detected in myocardial tissues using western blot analysis. The gene expression levels of collagen type I α-2 chain and collagen type III α-1 chain were detected using reverse transcription-quantitative PCR and the quantification of myocardial H(2)S content was performed using ELISA. In the Dox group compared with that in the control group, myocardial fibers were significantly disordered, while the protein expression levels of ERS-related and autophagy-related proteins were increased markedly, and the expression levels of PI3K/AKT/mTOR proteins were reduced markedly. The aforementioned changes were markedly reversed following H(2)S intervention, which indicated that H(2)S exerts a positive protective effect on doxorubicin-induced myocardial fibrosis. The protective mechanism of H(2)S intervention in myocardial fibrosis is hypothesized to be associated with the inhibition of overactivation of the ER and that of autophagy via upregulation of the PI3K/AKT/mTOR pathway.
format Online
Article
Text
id pubmed-7930940
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-79309402021-03-09 Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway Nie, Liangui Liu, Maojun Chen, Jian Wu, Qian Li, Yaling Yi, Jiali Zheng, Xia Zhang, Jingjing Chu, Chun Yang, Jun Mol Med Rep Articles The present study aimed to determine the role and regulatory mechanism of hydrogen sulfide (H(2)S) in the amelioration of doxorubicin-induced myocardial fibrosis in rats. It is hypothesized that the PI3K/AKT/mTOR signaling pathway is regulated to inhibit endoplasmic reticulum stress (ERS) and autophagy to reduce myocardial fibrosis. A total of 40 adult male Sprague Dawley rats were randomly divided into 4 groups (n=10/group). The 4 groups included the normal control group (control group), model group [doxorubicin (Dox) group], H(2)S intervention model group (H(2)S+Dox group) and H(2)S control group (H(2)S group). The model used in the present study was constructed by administering intraperitoneal injections of doxorubicin (3.0 mg/kg every other day; total of 6 injections). In addition, the intervention factor, NaHS and the donor of H(2)S, was also administered by intraperitoneal injection (56 µmol/kg/day), which lasted a month. Pathological changes in the rats were observed using Masson staining and transmission electron microscopy, while the protein expression levels of MMPs/TIMPs, transforming growth factor-β1, cystathionine lyase and PI3K/AKT/mTOR, which are autophagy-related and ERS-related proteins were detected in myocardial tissues using western blot analysis. The gene expression levels of collagen type I α-2 chain and collagen type III α-1 chain were detected using reverse transcription-quantitative PCR and the quantification of myocardial H(2)S content was performed using ELISA. In the Dox group compared with that in the control group, myocardial fibers were significantly disordered, while the protein expression levels of ERS-related and autophagy-related proteins were increased markedly, and the expression levels of PI3K/AKT/mTOR proteins were reduced markedly. The aforementioned changes were markedly reversed following H(2)S intervention, which indicated that H(2)S exerts a positive protective effect on doxorubicin-induced myocardial fibrosis. The protective mechanism of H(2)S intervention in myocardial fibrosis is hypothesized to be associated with the inhibition of overactivation of the ER and that of autophagy via upregulation of the PI3K/AKT/mTOR pathway. D.A. Spandidos 2021-04 2021-02-24 /pmc/articles/PMC7930940/ /pubmed/33649809 http://dx.doi.org/10.3892/mmr.2021.11938 Text en Copyright: © Nie et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Nie, Liangui
Liu, Maojun
Chen, Jian
Wu, Qian
Li, Yaling
Yi, Jiali
Zheng, Xia
Zhang, Jingjing
Chu, Chun
Yang, Jun
Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title_full Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title_fullStr Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title_full_unstemmed Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title_short Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway
title_sort hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the pi3k/akt/mtor pathway
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930940/
https://www.ncbi.nlm.nih.gov/pubmed/33649809
http://dx.doi.org/10.3892/mmr.2021.11938
work_keys_str_mv AT nieliangui hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT liumaojun hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT chenjian hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT wuqian hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT liyaling hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT yijiali hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT zhengxia hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT zhangjingjing hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT chuchun hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway
AT yangjun hydrogensulfideamelioratesdoxorubicininducedmyocardialfibrosisinratsviathepi3kaktmtorpathway